CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,154 | -5.4% | 51,190 | 0.0% | 0.00% | – |
| Q2 2023 | $75,249 | -10.9% | 51,190 | 0.0% | 0.00% | – |
| Q1 2023 | $84,464 | +17.9% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $71,666 | -9.3% | 51,190 | 0.0% | 0.00% | – |
| Q3 2022 | $79,000 | -30.1% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $113,000 | -11.0% | 51,190 | 0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -58.8% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $308,000 | -11.7% | 51,190 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $349,000 | +2.6% | 52,349 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $340,000 | -35.8% | 51,190 | -10.5% | 0.00% | -50.0% |
| Q1 2021 | $530,000 | -76.4% | 57,220 | -54.1% | 0.00% | -75.0% |
| Q4 2020 | $2,245,000 | – | 124,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |